Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME's) Human Papillomavirus (HPV) and Cervical Cancer Study

International Journal of Epidemiology

Volumn 46, Issue 6, 2017, Pages

  Adebamowo, Sally N ^a,b,c   Dareng, Eileen O ^d   Famooto, Ayotunde O ^e   Offiong, Richard ^f   Olaniyan, Olayinka ^g   Obende, Kayode ^h   Adebayo, Amos ⁱ   Ologun, Sanni ^j   Alabi, Bunmi ^k   Achara, Peter ^l   Bakare, Rasheed A ^m   Odutola, Michael ^e   Olawande, Oluwatoyosi ^e   Okuma, James ^e   Odonye, George ^e   Adebiyi, Ruxton ^e   Dakum, Patrick ^e   Adebamowo, Clement A ^a,b,c,e,n   Adeyemo, Adebowale ⁿ   Aminu, Yakubu ⁿ   Hildesheim, Alan ⁿ   Lorincz, Attila ⁿ   Mensah, Charles ⁿ   James, Jesse ⁿ   Oyafajo, Kunle ⁿ   Ogundipe, Mojisola ⁿ   Owoade, Adeyinka ⁿ   Ravel, Jacques ⁿ   Reuter, Caroline ⁿ   Rotimi, Charles ⁿ   Vasiljević, Nataša ⁿ   Wheeler, Cosette ⁿ   Omenuko, Gladys ⁿ   Akabueze, Onyeka Gerald ⁿ   Akpobome, Bernice Oghogho ⁿ   Akpomiemie, Stella ⁿ   Dwana, Grace Kube ⁿ   Fagbohun, Azeezat Tolani ⁿ   Gbolahan, Toluwalope Omotola ⁿ   Odoh, Ifeanyichukwu ⁿ   Okoh, Ene ⁿ   Filade, Temitope ⁿ   Chinye, Osa Afina ⁿ   Abdulsalam, Kofoworola Maryam ⁿ   Adelakun, Oluwakukunmi Deborah ⁿ   Erhunmwonsere, Iyobosa Juliet ⁿ   Olukomogbon, Temitope ⁿ   Nwoko, Abimbola Florence ⁿ   Yusuf, Ibrahim ⁿ   Oguoma, Tochukwu Godson ⁿ   Lenny Iwaloye, Aderonke Rachael ⁿ   Ojo, Christianah Bukola ⁿ   Yohanna, Snythche ⁿ   Oluwole, Uyoyo Sefunmi ⁿ   Oguama, Edith Uzoamaka ⁿ   Jesse, Dorcas ⁿ   Abdullahi, Sarahatu ⁿ   Kosi, Blessing ⁿ   Omole, Aderonke ⁿ   more..

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^f UNIVERSITY OF ABUJA   (Nigeria)

^g NATIONAL HOSPITAL   (Nigeria)

^h Department of Anaesthesia   (Nigeria)

ⁱ Asokoro Hospital   (Nigeria)

^j Kubwa General Hospital Abuja   (Nigeria)

^k Wuse General Hospital   (Nigeria)

^l FEDERAL MEDICAL CENTER   (Nigeria)

^m UNIVERSITY OF IBADAN   (Nigeria)

ⁿ UNIVERSITY OF MARYLAND   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CELLS AND CELL COMPONENTS; COHORT ANALYSIS; GENOMICS; HETEROGENEITY; PUBLIC HEALTH; RISK FACTOR; VIRUS;

ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENOMICS; HUMAN; LABORATORY; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX CANCER; WART VIRUS; ADOLESCENT; ADULT; BLACK PERSON; LONGITUDINAL STUDY; MICROFLORA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX TUMOR; YOUNG ADULT;

UNITED STATES;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; FEMALE; GENOMICS; HUMANS; LONGITUDINAL STUDIES; MICROBIOTA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 85039543433     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyx050     Document Type: Article

References (59)

1. IARC. Globocon 2012:Estimated Incidence, Mortality and PrevalenceWorldwide in 2012. 2012. [http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (November 2014, date last accessed)
2. Jedy-Agba E, Oga E, Odutola M et al. Cancer incidence in Nigeria from 2009 to 2013. Ann Glob Health 2015;81:92
3. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide:IARC CancerBase No. 1.1. 2013. http://globocan.iarc.fr (20 December 2013, date last accessed)
4. Forman D, de Martel C, Lacey CJ et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30(Suppl 5): F12-23
5. Stanley M. Immunobiology of HPV and HPV vaccines. Gynecol Oncol 2008;109(Suppl 2):S15-21
6. Brown DR, Shew ML, Qadadri B et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005;191:182-92
7. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(Suppl 1):S1-15
8. McCredie MRE, Sharples KJ, Paul C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34
9. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50
10. Dartell M, Rasch V, Kahesa C et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis 2012;39:201-08
11. Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis 2013;13:521
12. Akarolo-Anthony SN, Famooto AO, Dareng EO et al. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health 2014;14:656
13. Dalal S, Beunza JJ, Volmink J et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 2011;40:885-901
14. Holmes MD, Dalal S, Volmink J et al. Non-communicable diseases in sub-Saharan Africa. Part II-The case for cohort studies. PLoS Med 2010;7:e1000244
15. Smith JS, Lindsay L, Hoots B et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-32
16. Walboomers JM, Jacobs MV, ManosMMet al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
17. Schmeink CE, Melchers WJ, Siebers AG, Quint WG, Massuger LF, Bekkers RL.Human papillomavirus persistence in young unscreened women, a prospective cohort study. PloSOne 2011;6:e27937
18. Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide:Variation by geographical region, histological type and year of publication. Int J Cancer 2011;128:927-35
19. de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM. Susceptibility to cervical cancer: an overview. Gynecol Oncol 2012;126:304-11
20. Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters 2008;16:41-49
21. Denny L, Anorlu R. Cervical cancer in Africa. Cancer Epidemiol Biomarkers Prev 2012;21:1434-38
22. Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL. Cancer in twins:genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997;89:287-93
23. Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011;17:132-44
24. Zelmanowicz A, Hildesheim A. Family history of cancer as a risk factor for cervical carcinoma: A review of the literature. Papilloma Virus Rep 2004;15:113-20
25. Moore EE, Wark JD, Hopper JL, Erbas B, Garland SM; CeCaGeEn Study Group. The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies. Twin Res Hum Genet 2012;15:79-86
26. Magnusson PK, Lichtenstein P, Gyllensten UB. Heritability of cervical tumours. Int J Cancer 2000;88(5):698-701
27. Hemminki K, Dong C, Vaittinen P. Familial risks in cervical cancer: is there a hereditary component? Int J Cancer 1999;82:775-81
28. Benschop CC, Quaak FC, Boon ME, Sijen T, Kuiper I. Vaginal microbial flora analysis by next generation sequencing and microarrays; can microbes indicate vaginal origin in a forensic context? Int J Legal Med 2012;126:303-10
29. Fettweis JM, Serrano MG, Girerd PH, Jefferson KK, Buck GA. A new era of the vaginal microbiome: advances using nextgeneration sequencing. Chem Biodiversity 2012;9:965-76
30. Forney LJ, Gajer P, Williams CJ et al. Comparison of selfcollected and physician-collected vaginal swabs for microbiome analysis. J Clin Microbiol 2010;48:1741-48
31. Gloor GB, Hummelen R, Macklaim JM et al. Microbiome profiling by Illumina sequencing of combinatorial sequence-tagged PCR products. PloS One 2010;5:e15406
32. Hyman RW, Herndon CN, Jiang H et al. The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. J Assist Reprod Genet 2012; 29:105-15
33. Ma B, Forney LJ, Ravel J. Vaginal Microbiome: Rethinking Health and Disease. Ann Rev Microbiol 2012; 66:371-89
34. Ravel J, Gajer P, Abdo Z et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4680-87
35. Barton ES, White DW, Cathelyn JS et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007;447:326-29
36. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007;449:811-18
37. Schellenberg JJ, Links MG, Hill JE et al. Molecular definition of vaginal microbiota in East African commercial sex workers. Appl Environ Microbiol 2011;77:4066-74
38. Hummelen R, Fernandes AD, Macklaim JM et al. Deep sequencing of the vaginal microbiota of women with HIV. PloS One 2010;5:e12078
39. National Population Commission Nigeria Demographic and Health Survey. Abuja: NPC, 2013
40. Akinsoji AA, Olufunmilola AA, Idowu AA, Pius AO. Sexual and Contraceptive Practices among Female Undergraduates in a Nigerian Tertiary Institution. Ethiop J Health Sci 2015; 25:209-16
41. Yakasai IA, Ugwa EA, Otubu J. Gynecological malignancies in Aminu Kano Teaching Hospital Kano: a 3 year review. Niger J Clin Pract 2013;16:63-66
42. Umeora O, Egwuatu V. Age at menarche and the menstrual pattern of Igbo women of southeast Nigeria. Afr J Reprod Health 2008;12:90-95
43. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadatadriven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81
44. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 2001;38:115-32
45. Hamilton CM, Strader LC, Pratt JG et al. The PhenX Toolkit: get themost fromyourmeasures. Am J Epidemiol 2011;174:253-60
46. Akarolo-Anthony SN, Odubore FO, Yilme S et al. Pattern of dietary carbohydrate intake among urbanized adult Nigerians. Int J Food Sci Nutr 2013;64:292-99
47. Akarolo-Anthony SN, Adebamowo CA. Prevalence and correlates of leisure-time physical activity among Nigerians. BMC Public Health 2014;14:529
48. Akarolo-Anthony SN, Willett WC, Spiegelman D, Adebamowo CA. Obesity epidemic has emerged among Nigerians. BMC Public Health 2014;14:455
49. Pickering TG, Hall JE, Appel LJ et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 2005;7:102-09
50. WHO. MONICA Manual Part III: Population Survey. Section 1: Population SurveyData Component. 1997. http://www.thl.fi/publi cations/monica/manual/part3/iii-1.htm (30 September 2014, date last accessed)
51. Fergusson CM. Inspection, auscultation, palpation, and percussion of the abdomen. In: Walker HK HW, Hurst JW (eds). Clinical Methods: The History, Physical and Laboratory Examinations. 3rd edn. Boston, MA: Butterworths, 1990
52. Long WN. Pelvic examination. In: Walker HK HW, Hurst JW, (eds). Clinical Methods: The History, Physical and Laboratory Examinations. Boston, MA: Butterworths, 1990
53. Heinze T, Riedewald S, Saling E. Determination of vaginal pH by pH indicator strip and by pH micro electrode. J Perinat Med 1989;17:477-79
54. Huppert JS, Bates JR, Weber AF, Quinn N, Gaydos CA. Abnormal vaginal pH and Mycoplasma genitalium infection. J Pediatr Adolesc Gynecol 2013;26:36-39
55. Amgad M, Alfaar AS. Integrating Web 2.0 in Clinical Research Education in a Developing Country. J Cancer Educ 2014;29:536-40
56. Franklin JD, Guidry A, Brinkley JF. A partnership approach for Electronic Data Capture in small-scale clinical trials. J Biomed Inform 2011;44(Suppl 1):S103-08
57. Dupont A, Wheeler J, Herndon JE 2nd, et al. Use of tablet personal computers for sensitive patient-reported information. J SupportOncol 2009;7(3):91-7
58. Dareng EO, Ma B, Famooto AO et al. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Epidemiol Infect 2016;144:123-37
59. Famooto A, Almujtaba M, Dareng E et al. RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women. PloS One 2013;8:e66930